Thrombospondin 1 and type I repeat peptides of thrombospondin 1 specifically induce apoptosis of endothelial cells

Cancer Research

Volumn 57, Issue 9, 1997, Pages 1735-1742

  Guo, Neng Hua ^a   Krutzsch, Henry C ^a   Inman, John K ^b   Roberts, David D ^a,c  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAMPTOTHECIN; DNA FRAGMENT; FIBRONECTIN; FUMONISIN B1; HERBIMYCIN; OKADAIC ACID; PEPTIDE; PHORBOL 13 ACETATE 12 MYRISTATE; THROMBOSPONDIN; TRANSFORMING GROWTH FACTOR BETA; VANADIC ACID;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CATTLE; CELL PROLIFERATION; CONTROLLED STUDY; ENDOTHELIUM CELL; GROWTH INHIBITION; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

AMINO ACID SEQUENCE; ANIMALS; APOPTOSIS; CATTLE; CELL ADHESION; CELL DIVISION; CELLS, CULTURED; DNA FRAGMENTATION; ENDOTHELIUM, VASCULAR; EXTRACELLULAR MATRIX; FIBRONECTINS; MEMBRANE GLYCOPROTEINS; MOLECULAR SEQUENCE DATA; PEPTIDES; PHOSPHORYLATION; PROTEIN KINASE C; REPETITIVE SEQUENCES, NUCLEIC ACID; TETRADECANOYLPHORBOL ACETATE; THROMBOSPONDINS; TRANSFORMING GROWTH FACTOR BETA;

EID: 0030904193     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Juliano, R. L., and Haskill, S. Signal transduction from the extracellular matrix. J. Cell Biol., 120: 577-585, 1993.
2. Schaller, M. D., and Parsons, J. T. Focal adhesion kinase and associated proteins. Curr. Opin. Cell Biol., 6: 705-710, 1994.
3. Hannigan, G. E., Leung-Hagesteijn, C., Fitz-Gibbon, L., Coppolino, M. G., Radeva, G., Filmus, J., Bell, J. C., and Dedhar, S. Regulation of cell adhesion and anchorage-dependent growth by a new β1-integrin-linked protein kinase. Nature (Lond.), 379: 91-96, 1996.
4. Miyamoto, S., Teramoto, H., Coso, O. A., Gutkind, J. S., Burbelo, P. D., Akiyama, S. K., and Yamada, K. M. Integrin function: molecular hierarchies of cytoskeletal and signaling molecules. J. Cell Biol., 131: 791-805, 1995.
5. Vuori, K., and Ruoslahti, E. Activation of protein kinase C precedes α5β1 integrin-mediated cell spreading on fibronectin. J. Biol. Chem., 268: 21459-21462, 1993.
6. Zhang, Z., Vuori, K., Reed, J. C., and Ruoslahti, E. The α5β1 integrin supports survival of cells on fibronectin and up-regulates Bcl-2 expression. Proc. Natl. Acad. Sci. USA, 92: 6161-6165, 1995.
7. Chen, Q., Kinch, M. S., Lin, T. H., Burridge, K., and Juliano, R. L. Integrin-mediated cell adhesion activates mitogen-activated protein kinases. J. Biol. Chem., 269: 26602-26605, 1994.
8. Meredith, J. E., Jr., Fazeli, B., and Schwartz, M. A. The extracellular matrix as a cell survival factor. Mol. Biol. Cell, 4: 953-961, 1993.
9. Re, F., Zanetti, A., Sironi, M., Polentarutti, N., Lanfrancone, L., Dejana, E., and Colotta, F. Inhibition of anchorage-dependent cell spreading triggers apoptosis in cultured human endothelial cells. J. Cell Biol., 127: 537-546, 1994.
10. Brooks, P. C., Montgomery, A. M., Rosenfeld, M., Reisfeld, R. A., Hu, T., Klier, G., and Cheresh, D. A. Integrin αvβ3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell, 79: 1157-1164, 1994.
11. Brooks, P. C., Stromblad, S., Klemke, R., Visscher, D., Sarkar, F. H., and Cheresh, D. A. Anti-integrin αvβ3 blocks human breast cancer growth and angiogenesis in human skin. J. Clin. Invest., 96: 1815-1822, 1995.
12. Bornstein, P. Diversity of function is inherent in matricellular proteins: an appraisal of thrombospondin I. J. Cell Biol., 130: 503-506, 1995.
13. Lahav, J. The functions of thrombospondin and its involvement in physiology and pathophysiology. Biochim. Biophys. Acta, 1182: 1-14, 1993.
14. Lahav, J. Thrombospondin inhibits adhesion of endothelial cells. Exp. Cell Res., 177: 199-204, 1988.
15. Murphy-Ullrich, J. E., and Hook, M. Thrombospondin modulates focal adhesions in endothelial cells. J. Cell Biol., 109: 1309-1319, 1989.
16. Taraboletti, G., Roberts, D., Liotta, L. A., and Giavazzi, R. Platelet thrombospondin modulates endothelial cell adhesion, motility, and growth: a potential angiogenesis regulatory factor. J. Cell Biol., 111: 765-772, 1990.
17. Bagavandoss, P., and Wilks, J. W. Specific inhibition of endothelial cell proliferation by thrombospondin. Biochem. Biophys. Res. Commun., 170: 867-872, 1990.
18. Good, D. J., Polverini, P. J., Rastinejad, F., Le, B. M., Lemons, R. S., Frazier, W. A., and Bouck, N. P. A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin. Proc. Natl. Acad. Sci. USA, 87: 6624-6628, 1990.
19. Iruela Arispe, M., Bornstein, P., and Sage, H. Thrombospondin exerts an antiangiogenic effect on cord formation by endothelial cells in vitro. Proc. Natl. Acad. Sci. USA, 88: 5026-5030, 1991.
20. Lawler, J., Weinstein, R., and Hynes, R. O. Cell attachment to thrombospondin: the role of Arg-Gly-Asp, calcium, and integrin receptors. J. Cell Biol., 107: 2351-2361, 1988.
21. Roberts, D. D. Regulation of tumor growth and metastasis by thrombospondin-1. FASEB J., 10: 1183-1191, 1996.
22. Tuszynski, G. P., and Nicosia, R. F. The role of thrombospondin-1 in tumor progression and angiogenesis. BioEssays, 18: 71-76, 1996.
23. Volpert, O. V., Stellmach, V., and Bouck, N. The modulation of thrombospondin and other naturally occurring inhibitors of angiogenesis during tumor progression. Breast Cancer Res. Treat., 36: 119-126, 1995.
24. Weinstat-Saslow, D. L., Zabrenetzky, V. S., VanHoutte, K., Frazier, W. A., Roberts, D. D., and Steeg, P. S. Transfection of thrombospondin 1 complementary DNA into a human breast carcinoma cell line reduces primary tumor growth, metastatic potential, and angiogenesis. Cancer Res., 54: 6504-6511, 1994.
25. Zabrenetzky, V., Harris, C. C., Steeg, P. S., and Roberts, D. D. Expression of the extracellular matrix molecule thrombospondin inversely correlates with malignant progression in melanoma, lung, and breast carcinoma cell lines. Int. J. Cancer, 59: 191-195, 1994.
26. Murphy-Ullrich, J. E., Gurusiddappa, S., Frazier, W. A., and Hook, M. Heparin-binding peptides from thrombospondins 1 and 2 contain focal adhesion-labilizing activity. J. Biol. Chem., 268: 26784-26789, 1993.
27. Vogel, T., Guo, N. H., Krutzsch, H. C., Blake, D. A., Hartman, J., Mendelovitz, S., Panet, A., and Roberts, D. D. Modulation of endothelial cell proliferation, adhesion, and motility by recombinant heparin-binding domain and synthetic peptides from the type I repeats of thrombospondin. J. Cell. Biochem., 53: 74-84, 1993.
28. Tolsma, S. S., Volpert, O. V., Good, D. J., Frazier, W. A., Polverini, P. J., and Bouck, N. Peptides derived from two separate domains of the matrix protein thrombospondin-1 have antiangiogenic activity. J. Cell Biol., 122: 497-511, 1993.
29. Schultz-Cherry, S., Chen, H., Mosher, D. F., Misenheimer, T. M., Krutzsch, H. C., Roberts, D. D., and Murphy-Ullrich, J. E. Regulation of transforming growth factor β activation by discrete sequences of thrombospondin 1. J. Biol. Chem., 270: 7304-7310, 1995.
30. Schultz-Cherry, S., and Murphy-Ullrich, J. E. Thrombospondin causes activation of latent transforming growth factor β secreted by endothelial cells by a novel mechanism. J. Cell Biol., 122: 923-932, 1993.
31. Roberts, D. D., Cashel, J., and Guo, N. Purification of thrombospondin from human platelets. J. Tissue Cult. Methods, 16: 217-222, 1994.
32. Akiyama, S. K., and Yamada, K. M. The interaction of plasma fibronectin with fibroblastic cells in suspension. J. Biol. Chem., 260: 4492-4500, 1985.
33. Guo, N. H., Krutzsch, H. C., Negre, E., Vogel, T., Blake, D. A., and Roberts, D. D. Heparin- and sulfatide-binding peptides from the type I repeats of human thrombospondin promote melanoma cell adhesion. Proc. Natl. Acad. Sci. USA, 89: 3040-3044, 1992.
34. Guo, N. H., Krutzsch, H. C., Negre, E., Zabrenetzky, V. S., and Roberts, D. D. Heparin-binding peptides from the type I repeats of thrombospondin. Structural requirements for heparin binding and promotion of melanoma cell adhesion and chemotaxis. J. Biol. Chem., 267: 19349-19355, 1992.
35. Danielpour, D., Dart, L. L., Flanders, K. C., Roberts, A. B., and Sporn, M. B. Immunodetection and quantitation of the two forms of transforming growth factor β(TGF-β1 and TGF-β2) secreted by cells in culture. J. Cell. Physiol., 138: 79-86, 1989.
36. Kojima, S., and Rifkin, D. B. Mechanism of retinoid-induced activation of latent transforming growth factor β in bovine endothelial cells. J. Cell. Physiol., 155: 323-332, 1993.
37. Charpentier, A., Simmons-Menchaca, M., Yu, W., Zhao, B., Qian, M., Heim, K., Sanders, B. G., and Kline, K. RRR-α tocopherol succinate enhances TGF-β1,-β2, and -β3 and TGF-βR-II expression by human MDA-MB-435 breast cancer cells. Nutr. Cancer, 26: 237-250, 1996.
38. Havrilesky, L. J., Hurteau, J. A., Whitaker, R. S., Elbendary, A., Wu, S., Rodriguez, G. C., Bast, R. C., Jr., and Berchuck, A. Regulation of apoptosis in normal and malignant ovarian epithelial cells by transforming growth factor β. Cancer Res., 55: 944-948, 1995.
39. Cohen, P., Holmes, C. F., and Tsukitani, Y. Okadaic acid: a new probe for the study of cellular regulation. Trends Biochem. Sci., 15: 98-102, 1990.
40. Bose, R., Verheij, M., Haimovitz-Friedman, A., Scotto, K., Fuks, Z., and Kolesnick, R. Ceramide synthase mediates daunorubicin-induced apoptosis: an alternative mechanism for generating death signals. Cell. 82: 405-414, 1995.
41. Haimovitz-Friedman, A., Kan, C. C., Ehleiter, D., Persaud, R. S., McLoughlin, M., Fuks, Z., and Kolesnick, R. N. Ionizing radiation acts on cellular membranes to generate ceramide and initiate apoptosis. J. Exp. Med., 180: 525-535, 1994.
42. Haimovitz-Friedman, A., Balaban, N., McLoughlin, M., Ehleiter, D., Michaeli, J., Vlodavsky, I., and Fuks, Z. Protein kinase C mediates basic fibroblast growth factor protection of endothelial cells against radiation-induced apoptosis. Cancer Res., 54: 2591-2597, 1994.
43. Sage, E. H., and Bornstein, P. Extracellular proteins that modulate cell-matrix interactions: SPARC, tenascin, and thrombospondin. J. Biol. Chem., 266: 14831-14834, 1991.
44. Hannun, Y. A., and Obeid, L. M. Ceramide: an intracellular signal for apoptosis. Trends Biochem. Sci., 20: 73-77, 1995.
45. Defilippi, P., Bozzo, C., Volpe, G., Romano, G., Venturino, M., Silengo, L., and Tarono, G. Integrin-mediated signal transduction in human endothelial cells: analysis of tyrosine phosphorylation events. Cell Adhes, Commun., 2: 75-86, 1994.
46. Oikawa, T., Ogasawara, H., Sano, H., Shibata, K., and Omura, S. Possible functional groups responsible for inhibition of in vivo angiogenesis by herbimycin A. Biol. Pharm, Bull., 17: 1430-1432, 1994.
47. Nakashima, I., Pu, M. Y., Hamaguchi, M., Iwamoto, T., Rahman, S. M., Zhang, Y. H., Kato, M., Ohkusu, K., Katano, Y., Yoshida, T., Koga, Y., Isobe, K. I., and Nagase, F. Pathway of signal delivery to murine thymocytes triggered by co-cross-linking CD3 and Thy-1 for cellular DNA fragmentation and growth inhibition. J. Immunol., 151: 3511-3520, 1993.
48. Lesoon-Wood, L. A., Kim, W. H., Kleinman, H. K., Weintraub, B. D., and Mixson, A. J. Systemic gene therapy with p53 reduces growth and metastases of a malignant human breast cancer in nude mice. Hum. Gene Ther., 6: 395-405, 1995.